WebObjectives: To identify point-of-care (POC) and rapid nucleic acid amplification techniques (NAATs) for the diagnosis of chlamydia and gonorrhoea and assess their utility. Methods: Literature search for available POC and rapid NAATs. The performance from the best-performing assays were applied hypothetically to patients in the clinic in which 100 … WebAug 2, 2024 · Cepheid's GeneXpert Xpress is an efficient, streamlined, and scalable workflow solution that delivers CLIA waived molecular results. The GeneXpert Xpress system produces quality results without any specialized …
[PDF] Performance of the GeneXpert CT/NG Assay ... - Semantic …
WebThe Xpert CT/NG Assay provides qualitative results. No correlation can be drawn between the magnitude of the Ct value and the number of cells in an infected sample. Xpert … WebJan 3, 2024 · Background: We aimed to evaluate the clinical performance of the GeneXpert ® (Xpert) CT/NG assay for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) using urine and cervical swabs collected from patients in China. Methods: This study was conducted from September 2016 to September 2024 in three Chinese … robert dyas east grinstead opening times
Cepheid Rectal Sample Validation Study - Full Text View ...
WebChlamydia and Gonorrhea Specimen Collection and Transport Guide For multi-CollectTM Specimen Collection Kit Urine and Swab Specimen Storage and Transport: 1. The patient should not have urinated for at least one hour prior to sample collection. 2. Discard specimen collection swab; it is not required for urine specimen collection. 3. WebApr 9, 2024 · For chlamydia testing in women, the sensitivity (the ability for a test to correctly identify a patient with a disease) and specificity (the ability for a test to correctly identify a patient without a disease) were 87% and 99%, respectively, for urine samples compared to cervical samples.; For chlamydia testing in men, the sensitivity and … WebBackground: Vaginal swabs were recently U.S. Food and Drug Administration-cleared for detecting Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) using Gen-Probe Incorporated's APTIMA COMBO2 Assay (AC2). We assessed the APTIMA CT Assay (ACT) for CT, APTIMA GC Assay (AGC) for GC, and AC2 for both organisms using patient- and … robert dyas east grinstead